发明名称 |
CENICRIVIROC FOR THE TREATMENT OF HIV-2 INFECTION |
摘要 |
Cenicriviroc (CVC) is an orally active antagonist of ligand binding to C-C chemokine receptor type 5 (CCR5) and C-C chemokine receptor type 2 (CCR2). CVC blocks the binding of RANTES, MIP-1α, and MIP-1β to CCR5, and of MCP-1/CCL2 to CCR2. Methods of treating HIV-2 infection and related conditions comprising administration of CVC are provided herein. |
申请公布号 |
WO2015187663(A1) |
申请公布日期 |
2015.12.10 |
申请号 |
WO2015US33737 |
申请日期 |
2015.06.02 |
申请人 |
TOBIRA THERAPEUTICS, INC. |
发明人 |
LEFEBVRE, ERIC |
分类号 |
A61K31/4196;A61K31/5513;C07D403/14 |
主分类号 |
A61K31/4196 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|